HSBC Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

HSBC Holdings’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.31M	Sell	27,000 -293,100	-92%	-$39.6M	﹤0.01%	1268
2026 Q1	$40.8M	Buy	320,100 +19,100	+6%	+$2.38M	0.02%	559
2025 Q4	$36.9M	Buy	+301,000	New	+$34.5M	0.02%	575
2025 Q3	–	Sell	-44,600	Closed	-$3.7M	–	3195
2025 Q2	$3.7M	Buy	+44,600	New	+$3.56M	﹤0.01%	1260
2025 Q1	–	Sell	-294,600	Closed	-$26.5M	–	3304
2024 Q4	$26.5M	Buy	+294,600	New	+$28.5M	0.02%	662
2019 Q4	–	Sell	-27,000	Closed	-$2.06M	–	3206
2019 Q3	$2.06M	Buy	+27,000	New	+$2.24M	﹤0.01%	1581
2019 Q1	–	Sell	-31,000	Closed	-$2.22M	–	2908
2018 Q4	$2.22M	Buy	+31,000	New	+$2.5M	﹤0.01%	1461

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

HSBC Holdings's XBI Position: Q2 2026 in Review

HSBC Holdings reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 90% in Q2 2026, selling an estimated $88.4M and leaving 71,428 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #930.

HSBC Holdings first reported a position in XBI in Q2 2013 and has held it in 52 quarters since. The position peaked at $103M in Q4 2023. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

HSBC Holdings held 71,428 shares of State Street SPDR S&P Biotech ETF worth $11.4M as of Q2 2026.
HSBC Holdings sold 654,110 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $88.4M.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #930 holding.
HSBC Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 52 quarters since.
HSBC Holdings's State Street SPDR S&P Biotech ETF position peaked at $103M in Q4 2023.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.